CA2617897A1 - Procede pour le traitement de la dyspnee comprenant l'administration combinee de sels de tiotropium et de sels de salmeterol - Google Patents

Procede pour le traitement de la dyspnee comprenant l'administration combinee de sels de tiotropium et de sels de salmeterol Download PDF

Info

Publication number
CA2617897A1
CA2617897A1 CA002617897A CA2617897A CA2617897A1 CA 2617897 A1 CA2617897 A1 CA 2617897A1 CA 002617897 A CA002617897 A CA 002617897A CA 2617897 A CA2617897 A CA 2617897A CA 2617897 A1 CA2617897 A1 CA 2617897A1
Authority
CA
Canada
Prior art keywords
acid
salts
salmeterol
tiotropium
dyspnea
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002617897A
Other languages
English (en)
Inventor
Piet Cornelissen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim International GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2617897A1 publication Critical patent/CA2617897A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002617897A 2005-08-06 2006-08-02 Procede pour le traitement de la dyspnee comprenant l'administration combinee de sels de tiotropium et de sels de salmeterol Abandoned CA2617897A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05107267 2005-08-06
EP05107267.6 2005-08-06
PCT/EP2006/064957 WO2007017437A1 (fr) 2005-08-06 2006-08-02 Procédé pour le traitement de la dyspnée comprenant l’administration combinée de sels de tiotropium et de sels de salmétérol

Publications (1)

Publication Number Publication Date
CA2617897A1 true CA2617897A1 (fr) 2007-02-15

Family

ID=37056590

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002617897A Abandoned CA2617897A1 (fr) 2005-08-06 2006-08-02 Procede pour le traitement de la dyspnee comprenant l'administration combinee de sels de tiotropium et de sels de salmeterol

Country Status (4)

Country Link
EP (1) EP1959942A1 (fr)
JP (1) JP2009504603A (fr)
CA (1) CA2617897A1 (fr)
WO (1) WO2007017437A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7250426B2 (en) 2002-11-29 2007-07-31 Boehringer Ingelheim Pharma Gmbh & Co Kg Tiotropium-containing pharmaceutical combination for inhalation
CN108451936A (zh) * 2018-06-19 2018-08-28 杭州勃锐思莫生物医药科技有限责任公司 一种噻托溴铵吸入制剂在制备治疗肺癌药物中应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
US20040002548A1 (en) * 1999-05-12 2004-01-01 Boehringer Ingelheim Pharma Kg Medicament compositions containing anticholinergically-effective compounds and betamimetics
DE10056104A1 (de) * 2000-11-13 2002-05-23 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols
DE10209243A1 (de) * 2002-03-04 2003-09-18 Boehringer Ingelheim Pharma Neue Arzneimittelkombination zur Inhalation
JP2005504076A (ja) * 2001-09-14 2005-02-10 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト 新規な吸入用医薬組成物
DE10145438A1 (de) * 2001-09-14 2003-04-03 Boehringer Ingelheim Pharma Neue Arzneimittel zur Inhalation
DE10351663A1 (de) * 2002-12-20 2004-07-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverförmige Arzneimittel enthaltend ein Tiotropiumsalz und Salmeterolxinafoat
US20040152720A1 (en) * 2002-12-20 2004-08-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powdered medicaments containing a tiotropium salt and salmeterol xinafoate

Also Published As

Publication number Publication date
JP2009504603A (ja) 2009-02-05
WO2007017437A1 (fr) 2007-02-15
EP1959942A1 (fr) 2008-08-27

Similar Documents

Publication Publication Date Title
CA2368583C (fr) Nouvelles compositions medicamenteuses a base de composes a action anticholinergique et de .beta.mimetiques
AU2007202303B2 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
US20070128125A1 (en) Pharmaceutical Compositions Based on Tiotropium Salts and Salts of Salmeterol
CA2431565C (fr) Nouvelles compositions pharmaceutiques a base d'anticholinergiques et de ciclesonide
AU2003255289B2 (en) Inhalation medicaments containing a novel anticholinesterase drug in conjunction with corticosteroids and betamimetic drugs
US7332175B2 (en) Long-acting drug combinations for the treatment of respiratory complaints
WO2019142214A1 (fr) Composition pharmaceutique comprenant du tiotropium destinée à être inhalée
EP1651224B1 (fr) Medicaments pour inhalation comportant un agent a activite anticholinergique et un betamimetique
US20040048886A1 (en) Pharmaceutical compositions based on new anticholinergics and NK1 receptor antagonists
CA2582207A1 (fr) Medicaments administres par inhalation contenant un anticholinergique, du salmeterol et un steroide du groupe ciclesonide ou mometasone furoate
CA2617897A1 (fr) Procede pour le traitement de la dyspnee comprenant l'administration combinee de sels de tiotropium et de sels de salmeterol
NZ536284A (en) Medicaments containing steroids and a novel anticholinergic drug
CA2527178A1 (fr) Nouvelles combinaisons medicamenteuses a action prolongee utilisees pour traiter des maladies des voies respiratoires
CA2534128C (fr) Combinaison d'un anticholinergique et d'un steroide et leur utilisation dans le traitement de troubles respiratoires par inhalation
US20080031828A1 (en) Method for the Treatment of Dyspnea Comprising Combined Administration of Tiotropium Salts and Salts of Salmeterol
WO2012010854A1 (fr) Composition pharmaceutique
CA2650813A1 (fr) Combinaisons nouvelles de medicaments a longue duree d'action pour le traitement de maladies respiratoires
US20070072891A1 (en) Method for the Protection Against the Risk of Cardiac Disorders Comprising Administration of Tiotropium Salts
US20060228305A1 (en) Pharmaceutical compositions based on anticholinergics and inhibitors of tnf alpha synthesis or action
CA2491451A1 (fr) Nouvelles compositions medicamenteuses a base de nouveaux anticholinergiques et antagonistes du recepteur nk1

Legal Events

Date Code Title Description
FZDE Dead